The Alzheimer's Research Podcast
The Alzheimer's Research Podcast
Podcast Description
The Alzheimer's Research Podcast is a conversation-style podcast by the Alzheimer's Therapeutic Research Institute (ATRI) that provides valuable insights and information about Alzheimer's disease, cutting-edge research, and the impact of studies and trials. The podcast features in-depth discussions with ATRI researchers, scientists, study participants, and other experts in the field. Listen in to learn about the people behind the science, their roles, and work. In 2025, ATRI celebrates their 10-year anniversary and marks a “ten years closer to prevention” milestone, discussing what each guest considers to be the most significant moment in time for them and their particular subject matter area of expertise.
Podcast Insights
Content Themes
The podcast focuses on Alzheimer's disease research, clinical trials, and prevention strategies, with episodes discussing topics such as innovative treatments and key milestones in Alzheimer’s research, including personal stories from study participants and researchers.
Brought to you by the Alzheimer’s Therapeutic Research Institute (ATRI), The Alzheimer’s Research Podcast offers an inside look at the science, stories, and people driving progress in the fight against Alzheimer’s disease. Through engaging conversations with researchers, study participants, and leading experts, we explore the latest discoveries, ongoing clinical trials, and the real-world impact of groundbreaking studies.
Whether he’s leading a clinical trial or advising film and television writers on accurate portrayals of Alzheimer’s, Dr. Michael Rafii knows that clear, accessible communication matters. In this episode, Dr. Rafii joins the podcast to discuss his work as Medical Director of ATRI and Director of the Medical Safety Unit of ACTC. He shares a fascinating overview of his clinical research around developing new treatments for a genetic form of Alzheimer’s in people with Down syndrome and explains how Alzheimer’s research has evolved throughout his career. Dr. Rafii also discusses his approach to communicating complex medical topics in a way that’s clear and easy to understand.
Episode Recap:
- In this episode, we’re talking with ATRI Medical Director Dr. Michael Rafii (0:41)
- Can you tell us about your role at ATRI and the work you’re doing with Alzheimer’s clinical trials? (1:40)
- How did you get involved with Alzheimer’s research, and how has it evolved? (4:29)
- Can you tell us about your work at the intersection of Alzheimer’s and Down syndrome? (11:15)
- How do genetics connect to Alzheimer’s risk? (20:13)
- What are some of the barriers to research for people with Down syndrome? (22:52)
- How are you working to educate the next generation of researchers? (28:00)
- What are your hopes for the future of Alzheimer’s research? (34:25)
- Can you tell us more about what the current clinical studies are testing? (36:33)
- Why is clear, easy-to-understand communication so important in this space? (39:20)
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.